https://www.selleckchem.com/pr....oducts/lonafarnib-sc
for clinical studies, DRKS00006078. Registered 09 May 2014, https//www.drks.de/drks_web/navigate.....do?navigationId=tria . HTMLTRIAL_ID=DRKS00006078. To investigate the performance of diffusion-weighted (DW) MRI with mono-, bi- and stretched-exponential models in predicting pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) for breast cancer, and further outline a predictive model of pCR combining DW MRI parameters, contrast-enhanced (CE) MRI findings, and/or clinical-pathologic variables. In this retro
Like
Comment
Share
